Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 5/2009

01-10-2009 | Erratum

Erratum to: Genomic profiling of breast tumours in relation to BRCAabnormalities and phenotypes

Authors: Olafur Andri Stefansson, Jon Gunnlaugur Jonasson, Oskar Thor Johannsson, Kristrun Olafsdottir, Margret Steinarsdottir, Sigridur Valgeirsdottir, Jorunn Erla Eyfjord

Published in: Breast Cancer Research | Issue 5/2009

Login to get access

Excerpt

Following the publication of our article [1] we noticed an error in the article PDF. …
Literature
1.
Stefansson OA, Jonasson JG, Johannsson OT, Olafsdottir K, Steinarsdottir M, Valgeirsdottir S, Eyfjord JE: Genomic profiling of breast tumours in relation to BRCA abnormalities and phenotypes. Breast Cancer Research. 2009, 11: R47-10.1186/bcr2334.CrossRefPubMedPubMedCentral
Metadata
Title
Erratum to: Genomic profiling of breast tumours in relation to BRCAabnormalities and phenotypes
Authors
Olafur Andri Stefansson
Jon Gunnlaugur Jonasson
Oskar Thor Johannsson
Kristrun Olafsdottir
Margret Steinarsdottir
Sigridur Valgeirsdottir
Jorunn Erla Eyfjord
Publication date
01-10-2009
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 5/2009
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr2355

Other articles of this Issue 5/2009

Breast Cancer Research 5/2009 Go to the issue

Editorial

Notch versus the proteasome: what is the target of γ-secretase inhibitor-I?

Research article

Estrogen and progesterone receptors have distinct roles in the establishment of the hyperplastic phenotype in PR-A transgenic mice

Editorial

Development of 'synthetic lethal' strategies to target BRCA1-deficient breast cancer

Review

Key signalling nodes in mammary gland development and cancer: Myc

Research article

The membrane mucin MUC4 is elevated in breast tumor lymph node metastases relative to matched primary tumors and confers aggressive properties to breast cancer cells

Editorial

Circulating tumor cells in blood of primary breast cancer patients assessed by a novel RT-PCR test kit and comparison with status of bone marrow-disseminated tumor cells
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits